121 related articles for article (PubMed ID: 3096046)
1. Growth hormone response to thyrotropin-releasing hormone in children and adolescents: a reappraisal.
Theintz GE; Tang JZ; Marti C; Bischof P; Sizonenko PC
Acta Endocrinol Suppl (Copenh); 1986; 279():51-9. PubMed ID: 3096046
[TBL] [Abstract][Full Text] [Related]
2. The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.
Arteaga E; Valenzuelaa P; Cattani A; del Valle M
J Endocrinol Invest; 1989 Sep; 12(8):543-8. PubMed ID: 2512341
[TBL] [Abstract][Full Text] [Related]
3. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
4. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
[TBL] [Abstract][Full Text] [Related]
5. 24-hour secretion of growth hormone (GH), insulin-like growth factors-I and -II (IGF-I, -II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature.
Stratakis CA; Mastorakos G; Magiakou MA; Papavasiliou EC; Panitsa-Faflia C; Georgiadis E; Batrinos ML
Endocr Res; 1996 Aug; 22(3):261-76. PubMed ID: 8875138
[TBL] [Abstract][Full Text] [Related]
6. Constitutionally tall stature with morphological abnormality of the pituitary gland.
Miyata I; Yoshikawa H; Eto Y
Endocr J; 2004 Apr; 51(2):189-95. PubMed ID: 15118269
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
[TBL] [Abstract][Full Text] [Related]
8. Studies in constitutionally tall adolescents. II. Effects of bromocriptine on growth hormone secretion and adult height prediction.
Evain-Brion D; Garnier P; Blanco-Garcia M; Job JC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1022-6. PubMed ID: 6427255
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
10. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
Watanobe H; Tamura T; Sasaki S; Takebe K
Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
[TBL] [Abstract][Full Text] [Related]
11. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
12. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion in children and adolescents with familial tall stature.
Tauber M; Pienkowski C; Rochiccioli P
Eur J Pediatr; 1994 May; 153(5):311-6. PubMed ID: 8033917
[TBL] [Abstract][Full Text] [Related]
14. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
Jeppsson S; Nilsson KO; Rannevik G; Wide L
Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue.
Yang IM; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Clin Endocrinol (Oxf); 1995 Mar; 42(3):295-301. PubMed ID: 7758235
[TBL] [Abstract][Full Text] [Related]
16. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
Cara JF; Kreiter ML; Rosenfield RL
J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
19. Studies in constitutionally tall adolescents: somatostatin decrease associated with growth hormone increase after TRH injection.
Garcia Blanco M; Evain Brion D
Clin Endocrinol (Oxf); 1984 Oct; 21(4):459-63. PubMed ID: 6150770
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone release induced by growth hormone-releasing hexapeptide is not mediated by thyrotropin-releasing hormone in neonatal rats.
Kacsóh B; Kacsóh G; Guzzardo MB; Black AC; Bisat T
Pediatr Res; 1997 Feb; 41(2):249-57. PubMed ID: 9029647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
